GB 19083-2023 English PDF

Delivery: 2 working-hours manually (Sales@ChineseStandard.net)
Need delivered in 3-second? USA-Site: GB 19083-2023
Get Quotation: Click GB 19083-2023 (Self-service in 1-minute)
Historical versions (Master-website): GB 19083-2023
Preview True-PDF (Reload/Scroll-down if blank)

GB 19083-2023: Protective face mask for medical use
GB 19083-2023
GB
NATIONAL STANDARD OF THE
PEOPLE?€?S REPUBLIC OF CHINA
ICS 11.100
CCS C 44
Replacing GB 19083-2010
Protective face mask for medical use
ISSUED ON: NOVEMBER 27, 2023
IMPLEMENTED ON: DECEMBER 01, 2025
Issued by: State Administration for Market Regulation;
Standardization Administration of the People?€?s Republic of China.
Table of Contents
Foreword ... 4
1 Scope ... 5
2 Normative references ... 5
3 Terms and definitions ... 6
4 Requirements ... 7
4.1 Basic requirements ... 7
4.2 Mask belt connection strength ... 7
4.3 Filtration efficiency ... 7
4.4 Respiratory resistance ... 7
4.5 Dead space ... 8
4.6 Total inward leakage ... 8
4.7 Resistance against penetration by synthetic blood ... 8
4.8 Microbiological indicators ... 8
4.9 Ethylene oxide residue (if applicable) ... 8
4.10 Flammability (if applicable) ... 8
4.11 Biocompatibility... 8
5 Test methods ... 9
5.1 Test conditions ... 9
5.2 Basic requirements ... 9
5.3 Temperature and humidity pretreatment conditions ... 9
5.4 Mask belt connection strength ... 9
5.5 Filtration efficiency ... 10
5.6 Respiratory resistance ... 11
5.7 Dead space ... 13
5.8 Total inward leakage ... 14
5.9 Resistance against penetration by synthetic blood ... 15
5.10 Microbiological indicators ... 15
5.11 Residue of ethylene oxide ... 15
5.12 Flammability ... 15
5.13 Biocompatibility ... 16
6 Marking and instruction for use ... 16
6.1 Marking ... 16
6.2 Instructions for use ... 17
7 Packaging and storage ... 17
7.1 Packaging ... 17
7.2 Storage ... 17
Appendix A (Informative) Fit test method before mask selection ... 18
Bibliography ... 23
Protective face mask for medical use
1 Scope
This document specifies the requirements, markings, instructions for use, as well as
packaging and storage of disposable protective face mask for medical use (hereinafter
referred to as ?€?face mask?€?), and describes the corresponding test methods.
This document is applicable to non-powered air-purifying face masks (half masks) for
filtering particles in the air and blocking droplets, blood, body fluids, secretions, etc. in
medical working environments.
This document does not apply to masks that protect against any chemical gases and
vapors.
2 Normative references
The following documents are referred to in the text in such a way that some or all of
their content constitutes requirements of this document. For dated references, only the
version corresponding to that date is applicable to this document; for undated references,
the latest version (including all amendments) is applicable to this document.
GB 2626-2019, Respiratory protection - Non-powered air-purifying particle
respirator
GB/T 14233.1-2022, Test methods for infusion, transfusion, injection equipment
for medical use - Part 1: Chemical analysis methods
GB/T 16886.5, Biological evaluation of medical devices - Part 5: Tests for in vitro
cytotoxicity
GB/T 16886.10, Biological evaluation of medical devices - Part 10: Tests for
irritation and skin sensitization
GB/T 16886.12, Biological evaluation of medical devices - Part 12: Sample
preparation and reference materials
GB/T 32610-2016, Technical specification of daily protective mask
YY 0469, Surgical mask
YY/T 0691-2008, Clothing for protection against infectious agents - Medical face
masks - Test method for resistance against penetration by synthetic blood (fixed
volume, horizontally projected)
YY/T 0866, Total inward leakage determination method of protective face mask
for medical use
Pharmacopoeia of the People?€?s Republic of China 2020 Edition Volume IV
ISO 16900-5:2016/Amd.1:2018, Respiratory protective devices - Methods of test
and test equipment - Part 5: Breathing machine, metabolic simulator, RPD
headforms and torso, tools and verification tools/Amendment 1: RPD head forms
front and side view
3 Terms and definitions
For the purposes of this document, the following terms and definitions apply.
3.1
filtering efficiency
The percentage of particulate matter filtered out by the mask under specified test
conditions.
3.2
dead space
The volume of air that is re-inhaled from the previous exhalation.
Note: It is expressed by the volume fraction of CO2 in the inhaled gas.
[Source: GB/T 12903-2008, 5.3.10]
3.3
total inward leakage; TIL
The ratio of the concentration of the simulated agent leaking into the mask from all
parts including the mask when the subject inhales TO the concentration of the simulated
agent in the test environment under the test conditions specified in the laboratory.
[Source: GB/T 12903-2008, 5.3.7, modified]
3.4
fit
The degree of fit between the periphery of the mask and the specific user?€?s face.
4.5 Dead space
The average volume fraction of CO2 in inhaled air shall not exceed 1%.
4.6 Total inward leakage
The total inward leakage shall meet the requirements in Table 1.
4.7 Resistance against penetration by synthetic blood
Spray 2 mL of synthetic blood onto the mask at a pressure of 16 kPa (120 mmHg), and
there shall be no penetration on the inside of the mask.
4.8 Microbiological indicators
4.8.1 Sterile masks shall be sterile.
4.8.2 The total number of microorganisms in non-sterile masks shall be less than or
equal to 100 CFU/g.
4.9 Ethylene oxide residue (if applicable)
If the mask has been ethylene oxide-sterilized or disinfected, its ethylene oxide residue
shall not exceed 10 ??g/g.
4.10 Flammability (if applicable)
If the manufacturer expressly states that the mask material is not flammable, when
testing according to 5.12, the after-flame time shall not exceed 5 seconds.
4.11 Biocompatibility
4.11.1 Skin irritation
The primary stimulation score shall not be greater than 0.4.
4.11.2 Cytotoxicity
The relative cell proliferation rate (survival rate) shall not be less than 70%.
4.11.3 Delayed type hypersensitivity
Delayed type hypersensitivity shall not be greater than grade 1.
5 Test methods
5.1 Test conditions
Except for special requirements, the test shall be carried out in an environment with a
temperature of 16 ??C ~ 32 ??C and a relative humidity of (50??30)%.
5.2 Basic requirements
Randomly select at least 3 masks from 3 minimum independent packaging units,
visually inspect and actually wear them, and check whether they meet the requirements
of 4.1.
5.3 Temperature and humidity pretreatment conditions
Remove the sample packaging and perform pretreatment in the following order:
a) Place in an environment of (38??2.5) ??? and (85??5)% relative humidity for (24??1)
h;
b) Place in a dry environment of (70??3) ??C for (24??1) h;
c) Place in an environment of (-30??3) ??C for (24??1) h.
The pretreatment method used should avoid thermal shock, and allow the sample
temperature to return to room temperature for at least 4 hours before subsequent
pretreatment or testing.
5.4 Mask belt connection strength
5.4.1 Number of samples
Take at least 4 mask samples and perform temperature and humidity pretreatment
according to 5.3.
5.4.2 Testing methods
Fix the main body of the mask with the outer side of the mask facing up; cut the mask
belt from the middle; let the mask belt hang naturally; apply a static pull force of 10 N
at the end for 10 seconds. The mask belt and the connection must not be disconnected.
In case of disconnection, the disconnection part (mask belt or connection point) shall
be reported.
If there is no fixed connection between the mask belt and the mask body, the mask belt
shall be removed, with one end fixed, and the other end loaded with a static tension
force of 10 N for 10 seconds. The mask belt shall not be disconnected.
Keys:
1 ?€? aerosol generator;
2 ?€? compressed air source;
3 ?€? flow control module;
4 ?€? gas release (when the test flow rate is
lower than the spray flow rate);
5 ?€? air supply (when the test flow rate is
higher than the spray flow rate);
6 ?€? testing cabin;
7 ?€? mask;
8 ?€? two-way valve;
9 ?€? aerosol photometer 1;
10 ?€? aerosol photometer 1;
11 ?€? flow meter;
12 ?€? vacuum pump.
Figure 1 ?€? Schematic diagram of filtering efficiency testing device
5.5.3 Testing methods
When the detection flow rate is (85??4) L/min, carry out the loading test, and the total
loading amount shall be at least (50??5) mg.
Before starting the test, fix and seal the edge of the mask to keep the shape of the mask
consistent with the normal wearing mode; if necessary, use a special clamp. After the
test starts, record the filtering efficiency during the loading process. When the specified
loading capacity is not reached and the filtering efficiency is lower than the grade limit
required in 4.3, the test shall be stopped and the sample shall be judged to be unqualified.
When the specified loading capacity is reached and the filtering efficiency has not been
lower than the required limit of this grade, judge it to be qualified. Record the lowest
value during the test as the filtering efficiency of the mask.
5.6 Respiratory resistance
5.6.1 Number of samples
Take at least 4 mask samples and perform temperature and humidity pretreatment
according to 5.3.
5.6.2 Testing equipment and testing conditions
5.6.2.1 Test head form
The head form specified in Appendix D of GB 2626-2019, Appendix B of GB/T 32610-
2016 or ISO 16900-5:2016/Amd.1:2018 can be used.
5.6.2.2 Testing equipment and conditions
5.9 Resistance against penetration by synthetic blood
Take at least 4 masks and carry out the test according to the method specified in YY/T
0691-2008. If all the results meet the requirements of 4.7, judge it as qualified. For the
preparation method of synthetic blood, see YY 0469.
5.10 Microbiological indicators
5.10.1 Sterility
Carry out the test in accordance with the test methods for sterility inspection method
(General Chapter 1101) of the Pharmacopoeia of the People's Republic of China (2020
Edition, Volume IV). Carry out the treatment of the test sample and the inoculation
culture medium in accordance with the provisions of the dressing test sample in the
direct inoculation method.
5.10.2 Microbial limits
Carry out the test in accordance with the membrane-filter procedure stipulated in the
microbial enumeration method (General Chapter 1105) in the microbial limit inspection
of non-sterile products in Pharmacopoeia of the People's Republic of China (2020
edition, volume IV). Obtain the total number of microorganisms by adding the results
of the total number of aerobic bacteria, mold and yeast.
Preparation of test solution: Randomly select at least 2 smallest packages; take no less
than 10 g of the test sample; cut it into pieces and use a diluent containing 0.1% (volume
fraction) polysorbate 80 (or other non-bacterial surfactant) ?€? such as pH 7.0 sterile
sodium chloride-peptone buffer, or pH 7.2 phosphate buffer, or 0.9% sterile sodium
chloride solution ?€? to prepare a 1:50 (g/mL) test solution; mix thoroughly.
5.11 Residue of ethylene oxide
Carry out the test according to the method specified in 9.4 of GB/T 14233.1-2022.
5.12 Flammability
5.12.1 Number of samples
Take at least 4 mask samples and perform temperature and humidity pretreatment
according to 5.3.
5.12.2 Testing methods
Follow the following steps for testing. When all samples meet the requirements of 4.10,
judge them to be qualified.
a) Wear the mask on the metal head form, and set the distance between the top of
the burner and the lowest part of the mask (when placed directly facing the
burner) at (20??2) mm.
b) Adjust the flame height to (40??4) mm. Use a metal-isolated thermocouple probe
to measure the temperature of the flame at (20??2) mm above the top of the
burner, which shall be (800??5) ??C.
c) Pass the head form through the flame at a linear speed of (60??5) mm/s, and
record the combustion state of the mask after passing through the flame once.
5.13 Biocompatibility
5.13.1 Sample preparation
Mix the mask belt and the mask body materials according to the area ratio of 1:3 as a
test sample. Prepare the leach solution of the test sample in accordance with the
requirements of GB/T 16886.12.
5.13.2 Skin irritation
Carry out the test according to the primary skin irritation method specified in GB/T
16886.10.
5.13.3 Cytotoxicity
After using complete cell culture medium to dilute the test sample leach solution twice,
carry out the cytotoxicity test according to the MTT method in GB/T 16886.5. The
relative cell proliferation rate shall not be less than 70%.
5.13.4 Delayed type hypersensitivity
Use the maximum dose for delayed type hypersensitivity in guinea pigs specified in
GB/T 16886.10 for the test.
6 Marking and instruction for use
6.1 Marking
The minimum sales unit of masks shall be provided with a clear Chinese marking,
which shall at least include:
a) Product name and grade specified in this document;
b) Model and specifications;
c) Production date and/or batch number;
Appendix A
(Informative)
Fit test method before mask selection
A.1 Necessity
The fit of protective face mask for medical use is directly related to the protective effect
of the wearer during actual use. Due to differences in individual face shapes, efforts in
the design of protective mask products can only improve its fit among different
individuals, that is, it can achieve better facial fit in a larger proportion of the population,
but it cannot fit all wearers. For protective face masks for medical use of a certain model
and size, users need to conduct a fit test before selecting them to reduce the risk of
leakage from the fitting part.
A.2 Evaluation cycle
Changes in physical condition may change the fit of a user wearing a protective mask
of the same brand, model, and size. Influencing factors may include significant changes
in weight, changes in facial fitting parts (such as scars, dental corrections, etc.), and
reduction in wearing c...